Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
- PMID: 15214887
- PMCID: PMC7129386
- DOI: 10.1111/j.1469-0691.2004.00956.x
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
Abstract
Treatment of severe acute respiratory syndrome (SARS) is experimental, and the effectiveness of ribavirin-steroid therapy is unclear. Forty SARS patients with progressive disease after ribavirin treatment and 1.5 g of pulsed methylprednisolone were given either convalescent plasma (n = 19) or further pulsed methylprednisolone (n = 21) in a retrospective non-randomised study. Good clinical outcome was defined as discharge by day 22 following the onset of symptoms. Convalescent plasma was obtained from recovered patients after informed consent. Patients in the plasma group had a shorter hospital stay (p 0.001) and lower mortality (p 0.049) than the comparator group. No immediate adverse effects were observed following plasma infusion.
Similar articles
-
High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome.Am J Respir Crit Care Med. 2003 Dec 15;168(12):1449-56. doi: 10.1164/rccm.200306-766OC. Epub 2003 Aug 28. Am J Respir Crit Care Med. 2003. PMID: 12947028
-
Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.Respirology. 2004 Jun;9(2):173-83. doi: 10.1111/j.1440-1843.2004.00588.x. Respirology. 2004. PMID: 15182266 Free PMC article.
-
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 6;21(1):828. doi: 10.1186/s13063-020-04735-y. Trials. 2020. PMID: 33023671 Free PMC article.
-
[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].Antibiot Khimioter. 2011;56(7-8):42-6. Antibiot Khimioter. 2011. PMID: 22359870 Review. Russian.
-
SARS: pharmacotherapy.Respirology. 2003 Nov;8 Suppl:S25-30. doi: 10.1046/j.1440-1843.2003.00525.x. Respirology. 2003. PMID: 15018130 Review.
Cited by
-
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness.Front Immunol. 2024 Sep 9;15:1448720. doi: 10.3389/fimmu.2024.1448720. eCollection 2024. Front Immunol. 2024. PMID: 39315108 Free PMC article. Review.
-
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019.Infect Dis Immun. 2021 Apr 20;1(1):52-58. doi: 10.1097/01.ID9.0000733568.58627.47. eCollection 2021 Apr. Infect Dis Immun. 2021. PMID: 38630075 Free PMC article. Review.
-
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8. Narra J. 2022. PMID: 38449903 Free PMC article. Review.
-
Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma.Diseases. 2023 Aug 30;11(3):112. doi: 10.3390/diseases11030112. Diseases. 2023. PMID: 37754308 Free PMC article.
-
Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection.South Med J. 2023 May;116(5):427-433. doi: 10.14423/SMJ.0000000000001546. South Med J. 2023. PMID: 37137479 Free PMC article. Review.
References
-
- Lee N, Hui DS, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986–1994. - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith CS et al. A novel coronavirus associated severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953–1966. - PubMed
-
- Drosten C, Gunther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967–1976. - PubMed
-
- Centers for Disease Control and Prevention. Update: severe acute respiratory syndrome. MMWR 2003; 52: 388–390. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous